CHESTER, New York (WABC) -- Officials in Orange County addressed residents' concerns over reports that ICE is planning a new facility in the area. During a packed meeting in the town of Chester on ...
File - Chester Police Commissioner Katrina Blackwell addresses Chester city officials during a council meeting in August 2025. (Kenny Cooper/WHYY) From Philly and the Pa. suburbs to South Jersey and ...
The pharmaceutical industry says a popular class of targeted cancer therapies could one day replace chemotherapy and its potential for harsh side effects. There is still more work to be done to refine ...
While the race is on to develop antibody-drug conjugate (ADC) cancer treatments, so too is the competition to manufacture them. Hoping to gain an edge in the rapidly growing market are MilliporeSigma ...
EBC-129 has been granted FDA fast track designation for the treatment of pancreatic ductal adenocarcinoma, paving the way for development of this antibody-drug conjugate. EBC-129, a novel ADC for the ...
Crozer-Chester Medical Center closed its doors Friday, marking the end of Delaware County, Pennsylvania's largest health system. Crozer Health served Delco for generations, and its closure has caused ...
After months of efforts to save Crozer-Chester Medical Center, the Upland, Pennsylvania, hospital permanently closed Friday. The last couple dozen patients being treated at the hospital as of ...
Antibody-drug conjugates (ADCs) are a growing class of biotherapeutics that have transformed targeted therapy, especially in oncology. By making use of monoclonal antibodies’ specificity to deliver ...
Adcendo is adding $135 million to its arsenal, money that will go toward launching several antibody-drug conjugate (ADC) candidates into the clinic. California-based investor TCGX led the ...
ADC Therapeutics has stopped development of lead solid tumor candidate ADCT-601. The biotech axed the AXL-directed antibody-drug conjugate (ADC) after failing to show a favorable benefit-risk profile ...
PRINCETON, N.J.--(BUSINESS WIRE)--NJ Bio, Inc. and Charles River Laboratories, Inc. have announced a strategic alliance to offer complementary services to clients including early development and ...
The mother of late Linkin Park frontman Chester Bennington says she feels hurt and betrayed by the rap-rock band for launching its latest iteration without giving her a heads-up. “I feel betrayed.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results